Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hymecromone in Pulmonary Hypertension (SATURN)
NCT05128929Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hymecromone in pulmonary hypertension (PH), sponsored by Stanford University. Started Apr 2022; status: completed.
02
Drugs
hymecromone
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT05128929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05128929.